KC
Kyle Carver
DELAYED 1 MONTH
Chief Financial Officer
Evommune, Inc.
Filings
1
Companies
1
Latest
May 28, 2026
Transactions
Signal
Ticker / Company
Insider
Transaction
Value
Filed
70
EVMNCLUSTER 2
Evommune, Inc.
Kyle Carver
Chief Financial Officer
Sale
$415.1K
18,175 sh
Jun 1 11:59 PM
May 28, 2026
—
Evommune, Inc.
Kyle Carver
Chief Financial Officer
Option Exercise
$44.9K
15,000 sh
Jun 1 11:59 PM
May 28, 2026